Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
VC & PE life sciences companies to transform promising science into life-changing treatments.
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Monograph Capital's primary investment focus?
- Monograph Capital is a VC & PE firm that focuses on life sciences companies, aiming to transform promising science into life-changing treatments.
- What is Monograph Capital's most notable portfolio company?
- According to startupim data, Monograph Capital's most notable portfolio company is UroGen Pharma, founded in 2004, which has raised $522.2M.
- When did Monograph Capital make its first recorded investment?
- Monograph Capital made its first recorded investment in July 2023.
- What is Monograph Capital's sector concentration?
- Monograph Capital's investments are concentrated in the Health Tech & Life Sciences sector.
- What was the investment amount in Monograph Capital's recorded round?
- Monograph Capital invested $120,000,000 in a round in July 2023.
- Has Monograph Capital acted as a lead investor in its recorded rounds?
- No, Monograph Capital has not acted as a lead investor in its recorded investment rounds, with a lead investor share of 0%.
- What type of funding stage has Monograph Capital participated in?
- Monograph Capital has participated in a PIPE funding stage.